A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UAB Lung Health Center, Birmingham, Alabama, United States
Contact: Principal Investigator (Tejaswini Kulkarni, MD)Cedars Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Tanzira Zaman, MD)Paradigm Clinical Research Centers, LLC, San Diego, California, United States
Contact: Principal Investigator (Daniel Jones, MD)National Jewish Health, Denver, Colorado, United States
Contact: Principal Investigator (Evans Fernandez Perez, MD)Yale University School of Medicine, New Haven, Connecticut, United States
Contact: Principal Investigator (Danielle Antin-Ozerkis, MD)Cleveland Clinic Florida, Weston, Florida, United States
Contact: Principal Investigator (David Zisman, MD)Henry Ford Health, Detroit, Michigan, United States
Contact: Principal Investigator (Asif M. Abdul Hameed, MD)The Lung Research Center, LLC, Chesterfield, Missouri, United States
Contact: Principal Investigator (Neil Ettinger, MD)University of Kansas Medical Center, Kansas City, Missouri, United States
Contact: Principal Investigator (Mark Hamblin, MD)University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Adam Souter)Contact: Principal Investigator (Jason Lobo, MD)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Timothy Whelan, MD)El Paso Pulmonary Association, El Paso, Texas, United States
Contact: Principal Investigator (Carlo M. Hatem, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Mary Beth Scholand, MD)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Principal Investigator (Laura Glenn, MD, PhD)Launceston Respiratory and Sleep Centre, Launceston, Tasmania, Australia
Contact: Principal Investigator (Collin Chia, MD)Instytut Gruzlicy i Chrob Pluc, Warsaw, Poland, Poland
Contact: Principal Investigator (Katarzyna Lewandowska, MD)Salus Aegroti Praktyka Lekarska dr n. med. Grzegorz Gąsior, Sosnowiec, Silesian Voivodeship, Poland
Contact: Principal Investigator (Grzegorz Gasior, MD, PhD)Royal Papworth Hospital, Trumpington, Cambridge, United Kingdom
Contact: Principal Investigator (Helen Parfrey, MD)Royal Devon and Exeter Hospital, Exeter, Devon, United Kingdom
Contact: Principal Investigator (Michael Gibbons, MD)Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom
Contact: Principal Investigator (Manjit Cartlidge, MD)Royal Brompton Hospital, London, United Kingdom
Contact: Principal Investigator (Philip Molyneaux, MD)